2026 ASH®
Annual Meeting & Exposition December 12-15, 2026 ▪ New Orleans, Louisiana

Paper Details

Abstracts, authors, affiliations, and disclosures.

Saturday, December 12, 2026
02:00 p.m. - 03:30 p.m.
MCCNO - New Orleans Theatre B
Technology and Procedures, Omics Technologies, Computational Biology, Profiling, Biological Processes, Immune Mechanism, Metabolism, Diseases, Lymphoid Malignancies, Lymphomas, Hodgkin Lymphoma, B Cell Lymphoma, T Cell Lymphoma, Research, Translational Research, Study Population, Human
PAPER

233 A macrophage-associated CXCR3+ immune niche defines aggressive monomorphic epitheliotropic intestinal T-cell lymphoma

Jinuo Wang, MD, Zhongmin Zhang2, Fei Cheng3, Wenjun Wu, MD4, Luyi Tian5, Zhen Cai, MD,PhD6
1 The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
2 Guangzhou Medical University, Guangzhou, China
3 The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
4 The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
5 Guangzhou National Laboratory, Guangzhou, China
6 The First Affiliated Hospital, Zhejiang University School of Medicine, China, China

Background

Monomorphic epitheliotropic intestinal T-cell lymphoma (MEITL) is a rare and highly aggressive intestinal T-cell lymphoma with dismal survival and limited therapeutic options. However, the spatial immune organization of the tumor microenvironment and its clinical significance remain poorly understood. We aimed to define the spatial immune architecture of MEITL and identify clinically relevant tumor–immune niches. 

Methods

We integrated single-cell RNA sequencing, spatial transcriptomics and multiplex immunofluorescence to characterize the spatial immune architecture of MEITL. Tumor samples from 30 patients with MEITL diagnosed between December 2016 and June 2025 were retrospectively analyzed. Four representative treatment-naïve tumors underwent integrated single-cell RNA sequencing and spatial transcriptomic profiling to characterize cellular composition and spatial organization. Ligand–receptor analysis was performed to explore potential cell–cell communication pathways. Multiplex immunofluorescence for CD3, CD68, and CXCR3 validated spatial cellular architecture, and CXCR3 expression was evaluated by immunohistochemistry in 25 evaluable patients and correlated with overall survival.

Results

scRNA-seq identified a dominant malignant T/NK-like cell population together with multiple macrophage states, including inflammatory and immunoregulatory macrophage programs. In contrast, conventional NK cells were largely absent, suggesting that the immune microenvironment of MEITL is not characterized by effective innate cytotoxic surveillance. Malignant cells displayed marked transcriptional heterogeneity, with subsets showing activation of stress-response, inflammatory, cytotoxicity-related, and tissue-adaptation programs.

ST demonstrated that malignant cells and macrophages were not randomly distributed. In three of four profiled tumors, macrophages were consistently enriched within or immediately adjacent to malignant cell-dense regions, defining a reproducible macrophage-associated tumor niche. Spatial neighborhood enrichment analysis confirmed significantly increased interaction between macrophages and malignant cells compared with interactions involving other immune populations, with an enrichment score of 3.42 (P<0.001).

Macrophage-enriched regions exhibited coordinated changes in local immune composition and were associated with accumulation of CXCR3-expressing T cells. Ligand–receptor analysis identified several candidate communication pathways involving macrophages, malignant T/NK-like cells, dendritic cells, and stromal fibroblasts. Among these, the CXCL9/CXCL10–CXCR3 axis emerged as a biologically plausible mechanism linking macrophage activation to recruitment or retention of CXCR3? lymphocytes within malignant cell regions. Additional interaction signals involving macrophage–T-cell, macrophage–dendritic-cell, macrophage–fibroblast, and tumor–macrophage communication suggested that the macrophage-associated niche represents a multicellular ecosystem rather than an isolated binary interaction.

mIF independently validated the spatial observations. CD68? macrophages were preferentially localized in malignant cell-rich areas, and CD3?CXCR3? cells were enriched within macrophage-rich regions. These findings supported the existence of a macrophage-associated CXCR3? immune niche at the protein level and across complementary spatial platforms.

To determine the clinical significance of this niche, CXCR3 expression was assessed by immunohistochemistry in 25 evaluable patients. CXCR3 positivity was significantly associated with inferior OS. Patients with CXCR3-positive tumors had a median survival of 3 months compared with 10 months among CXCR3-negative patients (P=0.0279). The association remained clinically meaningful despite the limited sample size and the biological heterogeneity inherent to this rare lymphoma. Together, these data indicate that CXCR3 expression is not merely a phenotypic marker of infiltrating lymphocytes but may identify a spatially organized, macrophage-associated tumor microenvironment linked to aggressive disease behavior.

Conclusions

Integrative single-cell and spatial transcriptomic profiling identifies a macrophage-associated CXCR3+ immune niche that characterizes biologically aggressive MEITL and predicts poor survival. These findings establish spatial immune architecture as a clinically relevant determinant of disease biology in MEITL.

Zhen Cai, MD,PhD: No relevant conflicts of interest to declare.